Marketing-authorisation holder · Canada
Knight Therapeutics Inc.
120 medicines in 1 country, as authorisation holder.
Group structure
Part of
KnightPharmaceutical groupOther companies in the group
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 120
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACT CITALOPRAM30 mg · Tablet | Citalopram | Canada | Authorised | |
| AKYNZEO300 mg + 0.5 mg · Capsule | Netupitant, Palonosetron | Canada | Marketed | 2017 |
| ALOXI0.5 mg · Capsule | Palonosetron | Canada | Not marketed | 2012 |
| ALOXI0.25 mg / 5 ml · Solution | Palonosetron | Canada | Marketed | 2012 |
| ANACIN325 mg + 32 mg · Tablet | Acetylsalicylic acid, Caffeine | Canada | Not marketed | 2011 |
| ANAPEN0.3 mg / 0.3 ml · Solution | Epinephrine | Canada | Not marketed | 2009 |
| ANAPEN JUNIOR0.15 mg / 0.3 ml · Solution | Epinephrine | Canada | Not marketed | 2009 |
| ANTIZOL1 g / ml · Liquid | Fomepizole | Canada | Marketed | 2001 |
| BIJUVA0.5 mg + 100 mg · Capsule | Estradiol, Progesterone | Canada | Authorised | |
| BIJUVA1 mg + 100 mg · Capsule | Estradiol, Progesterone | Canada | Marketed | 2024 |
| CLASTEON400 mg · Capsule | Clodronic acid | Canada | Marketed | 2004 |
| CTP 3030 mg · Tablet | Citalopram | Canada | Marketed | 2007 |
| CYESTRA-352 mg + 0.035 mg · Tablet | Cyproterone, Ethinyl estradiol | Canada | Marketed | 2007 |
| DANTRIUM CAPSULES25 mg · Capsule | Dantrolene | Canada | Marketed | 1993 |
| DANTRIUM INTRAVENOUS20 mg / vial · Powder For Solution | Dantrolene | Canada | Marketed | 1993 |
| DEXEDRINE5 mg · Tablet | Dexamfetamine | Canada | Marketed | 1992 |
| DEXEDRINE SPANSULE15 mg · Capsule (Sustained-Release) | Dexamfetamine | Canada | Marketed | 1992 |
| DEXEDRINE SPANSULE10 mg · Capsule (Sustained-Release) | Dexamfetamine | Canada | Marketed | 1992 |
| DUVOID25 mg · Tablet | Bethanechol | Canada | Marketed | 1992 |
| DUVOID10 mg · Tablet | Bethanechol | Canada | Marketed | 1992 |
| DUVOID50 mg · Tablet | Bethanechol | Canada | Not marketed | 1992 |
| ENVARSUS PA1 mg · Tablet (Extended-Release) | Tacrolimus | Canada | Marketed | 2019 |
| ENVARSUS PA4 mg · Tablet (Extended-Release) | Tacrolimus | Canada | Marketed | 2019 |
| ENVARSUS PA0.75 mg · Tablet (Extended-Release) | Tacrolimus | Canada | Marketed | 2019 |
| EXELON6 mg · Capsule | Rivastigmine | Canada | Marketed | 2000 |